Misoprostol: a prostaglandin E1 analogue versus antacid in the prevention of stress ulcers in kidney transplant patients.
Alijani
M R
MR
Department of Surgery, Georgetown University Medical Center, Washington DC 20007.
Benjamin
S B
SB
Collen
M J
MJ
Foegh
M L
ML
D000527:Alprostadil / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations / Q000627:therapeutic use; D004386:Duodenum / Q000473:pathology; D005753:Gastric Mucosa / Q000473:pathology; D006801:Humans; D007413:Intestinal Mucosa / Q000473:pathology; D016030:Kidney Transplantation; D008276:Magnesium Hydroxide / Q000627:therapeutic use; D016595:Misoprostol; D010437:Peptic Ulcer / Q000517:prevention & control*; D013312:Stress, Physiological
D000863:Antacids; D000897:Anti-Ulcer Agents; D004338:Drug Combinations; D016595:Misoprostol; C013591:aluminum hydroxide, magnesium hydroxide, drug combination; D000536:Aluminum Hydroxide; D000527:Alprostadil; D008276:Magnesium Hydroxide